Novo Nordisk
NVO
#78
Rank
ยฃ159.63 B
Marketcap
ยฃ35.93
Share price
-0.27%
Change (1 day)
-57.20%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Cash on Hand

Cash on Hand as of September 2025 : ยฃ3.84 Billion

According to Novo Nordisk's latest financial reports the company has ยฃ3.84 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Novo Nordisk - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ2.92 B-16.76%
2023-12-31ยฃ3.51 B25.24%
2022-12-31ยฃ2.80 B42.29%
2021-12-31ยฃ1.97 B27.48%
2020-12-31ยฃ1.54 B-12.57%
2019-12-31ยฃ1.76 B-6.26%
2018-12-31ยฃ1.88 B-16.06%
2017-12-31ยฃ2.24 B-5.32%
2016-12-31ยฃ2.37 B17.36%
2015-12-31ยฃ2.02 B21.29%
2014-12-31ยฃ1.66 B2.74%
2013-12-31ยฃ1.62 B-8.08%
2012-12-31ยฃ1.76 B-9.93%
2011-12-31ยฃ1.96 B5.71%
2010-12-31ยฃ1.85 B21.53%
2009-12-31ยฃ1.52 B17.01%
2008-12-31ยฃ1.30 B79.38%
2007-12-31ยฃ0.72 B57.49%
2006-12-31ยฃ0.46 B0.25%
2005-12-31ยฃ0.46 B21.79%
2004-12-31ยฃ0.37 B29.14%
2003-12-31ยฃ0.29 B73.99%
2002-12-31ยฃ0.16 B-48.37%
2001-12-31ยฃ0.32 B146.11%
2000-12-31ยฃ0.13 B8.58%
1999-12-31ยฃ0.12 B64.37%
1998-12-31ยฃ74.23 M-29.96%
1997-12-31ยฃ0.10 B28.09%
1996-12-31ยฃ82.74 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
ยฃ11.24 B 192.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ7.44 B 93.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ12.38 B 222.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ7.84 B 104.00%๐Ÿ‡ซ๐Ÿ‡ท France